Outcome | Baseline | 2 weeks | 1 month | 3 months | 6 months | |||||
---|---|---|---|---|---|---|---|---|---|---|
BoNT-A | HA | BoNT-A | HA | BoNT-A | HA | BoNT-A | HA | BoNT-A | HA | |
AOFAS Ankle/Hindfoot score | 71.3 ± 11.6 | 70.0 ± 11.7 | 84.5 ± 8.8 | 82.9 ± 12.3 | 88.1 ± 12.1 | 88.1 ± 11.8 | 89.0 ± 7.3 | 88.1 ± 11.3 | 88.3 ± 7.2 | 86.4 ± 12.5 |
A.M.D. (95% CI) | 1.4 (-2.5, 5.4) | -0.2 (-4.1, 3.8) | 0.8 (-2.8, 4.4) | 1.9 (-1.7, 5.5) | ||||||
p b | 0.48 | 0.93 | 0.66 | 0.30 | ||||||
VAS pain scalea | 4.0 ± 1.8 | 3.9 ± 1.2 | 1.8 ± 1.2 | 1.8 ± 1.2 | 1.8 ± 1.3 | 1.7 ± 1.5 | 1.7 ± 1.2 | 1.7 ± 1.1 | 1.8 ± 0.9 | 1.7 ± 1.1 |
A.M.D. (95% CI) | -0.04 (-0.5, 0.5) | 0.01 (-0.6, 0.6) | 0.01 (-0.4, 0.5) | 0.1 (-0.3, 0.5) | ||||||
p b | 0.88 | 0.97 | 0.95 | 0.71 | ||||||
SLS | 25.0 ± 19.4 | 25.4 ± 16.0 | 34.1 ± 26.6 | 36.8 ± 22.5 | 36.9 ± 23.8 | 43.0 ± 18.6 | 36.8 ± 21.8 | 41.7 ± 19.6 | 36.5 ± 23.3 | 40.0 ± 20.0 |
A.M.D. (95% CI) | -2.3 (-6.3, 1.7) | -5.7 (-10.4, -1.0) | -4.6 (-9.7, 0.5) | -3.1 (-8.2, 2.1) | ||||||
p b | 0.26 | 0.02* | 0.08 | 0.24 | ||||||
TUGa | 8.4 ± 3.0 | 8.2 ± 2.5 | 7.2 ± 2.3 | 6.9 ± 2.4 | 6.5 ± 1.7 | 6.3 ± 1.9 | 6.6 ± 1.7 | 6.6 ± 2.0 | 6.8 ± 1.8 | 6.7 ± 2.1 |
A.M.D. (95% CI) | 0.1 (-0.3, 0.5) | 0.1 (-0.4, 0.5) | -0.1 (-0.6, 0.4) | -0.04 (-0.5, 0.5) | ||||||
p b | 0.59 | 0.72 | 0.56 | 0.88 | ||||||
Acetaminophena (tablets/week) | 16.0 ± 5.4 | 17.0 ± 6.4 | 8.4 ± 5.2 | 8.9 ± 4.9 | 8.3 ± 4.3 | 8.5 ± 3.2 | 8.7 ± 4.9 | 9.3 ± 3.6 | 9.2 ± 4.9 | 9.5 ± 6.0 |
A.M.D. (95% CI) | -0.1 (-1.6, 1.5) | 0.3 (-1.0, 1.5) | -0.1 (-1.5, 1.4) | 0.3 (-1.1, 1.7) | ||||||
p b | 0.93 | 0.67 | 0.94 | 0.66 |